Skip to content

Effect of probiotic on high risk of cardiovascular disease

Effect and mechanism of Lactobacillus plantarum J26 on high risk of cardiovascular disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088192
Enrollment
Unknown
Registered
2024-08-13
Start date
2024-08-19
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome

Interventions

Interventions:Subjects are instructed to take one capsule of probiotics daily for a total of 12 weeks
Placebo Control:Subjects are instructed to take one capsule of placebo daily for a total of 12 weeks

Sponsors

Department of Nutrition, School of Public Health, Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Local residents aged between 40-65 years old; • Central obesity defined as waist circumference =90 cm in males or =80 cm in females, Plus any two of the following four conditions i) Elevated triglycerides: serum triglycerides =150 mg/dL (1.7 mmol/L); ii) Reduced HDL cholesterol: serum HDL-c <40 mg/dL (1.03 mmol/L) in males or <50 mg/dL (1.29 mmol/L) in females; iii) Elevated blood pressure: systolic blood pressure =130 mmHg or diastolic blood pressure =85 mmHg; iv) Elevated fasting plasma glucose: fasting plasma glucose =100 mg/dL (5.6 mmol/L) 2. Irregular habit of taking probiotic containing products; Or those who have taken it in the past but have stopped for more than one month; 3. Informed consent and voluntary participation in the experiment.

Exclusion criteria

Exclusion criteria: • Acute illness or current evidence of acute or chronic inflammatory of infective diseases; • Presence of any systemic, cardiovascular diseases as well as severe hepatic and renal impairment, other endocrine disorders such as abnormal thyroid function, and tumours; • Presence of any psychotropic drugs or medication which might interfere with metabolic homoeostasis and gut microbiota, especially antibiotics and probiotics 4 weeks before recruitment • Women who were pregnant or intended to be pregnant during the study. • Allergy or hypersensitivity to the samples under test. • Mental illness rendering them unable to understand the nature, scope, and possible consequences of the study.

Design outcomes

Primary

MeasureTime frame
cardiometabolic risk factors;

Secondary

MeasureTime frame
gut microbiota;Gastrointestinal comfort;Sleep quality;Mental health;Liver function;Kidney function;routine urine;routine blood;

Countries

China

Contacts

Public ContactZhaoyan Liu

Department of Nutrition, School of Public Health, Sun Yat-Sen University

liuzhy235@mail.sysu.edu.cn+86 189 2275 2685

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026